.

Wednesday, November 13, 2013

SEQUENOM Analysis

SEQUENOM AnalysisABOUT SEQUENOMSEQUENOM, Inc., a ancestrals company, provides ancestral depth psychology products that translate genomic knowledge into super solutions for bio medical exam research and molecular medicine. The Company has created superior desoxyribonucleic acid analysis technology that efficiently and but measures genetic variation. Sequenom was founded in 1994 and has had remarkable success in its short history. Since its start-up in 1994, Sequenom has naturalised international operations, launched major products, achieved the second best initial exoteric offering in the biotechnology industry, and built a difficult metrical foot of top-notch customers. The Companys principal activity is to determine the medical impact of genes and genetic variations known as single floor polymorphisms. SEQUENOM dedicated to the gross revenue and support of the companys MassARRAY program, and to the continued expansion of DNA analysis applications for enforce with thi s strategy. It has created high-performance DNA analysis technology that efficiently and precisely measures genetic variation. Their proprietary MassARRAY organisation is a high performance DNA analysis platform that efficiently and precisely measures the substance of genetic target significant and variations therein. Sequenom has used MassARRAY technology and the companys encompassing collections of DNA samples from diseased and wellnessy individuals to trace disease-related genes that affect the health of significant portions of the population.
Order your essay at Orderessay and get a 100% original and high-quality custom paper within the required time frame.
Through high-density genome-wide scans Sequenom has identified to a greater extent than 60 nominee genes in breast, lung, prostate, and ski n cancers; central noisome system dis armys! ; metabolous and cardiovascular diseases; and musculoskeletal and inflammatory conditions. ground on its discoveries, Sequenom develops symptomatic content, and also outlicenses candidate target genes for diagnostic and therapeutic product development. Sequenom employs over 150 people worldwide, with offices in San Diego, Boston, Hamburg, and Brisbane. Since the launch of the MassARRAY system in 2000, Sequenom has sold over ampere-second systems and released a refreshful benchtop version of the platform, the MassARRAY Compact. BUSINESS MODELSNPs are special K genetic markers... If you requirement to get a full essay, order it on our website: OrderEssay.net

If you want to get a full information about our service, visit our page: write my essay

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.